![Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment | Nature Communications Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-20019-0/MediaObjects/41467_2020_20019_Fig1_HTML.png)
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment | Nature Communications
![Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine](https://www.thelancet.com/cms/attachment/1627be14-a160-49b1-87a4-c9d7e0061887/gr1_lrg.jpg)
Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine
![Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions | Cancer Cell International | Full Text Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-018-0594-z/MediaObjects/12935_2018_594_Fig1_HTML.png)
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions | Cancer Cell International | Full Text
![Fat density is a novel prognostic marker in patients with esophageal cancer - Clinical Nutrition ESPEN Fat density is a novel prognostic marker in patients with esophageal cancer - Clinical Nutrition ESPEN](https://clinicalnutritionespen.com/cms/attachment/a22980b0-4c92-42da-9448-c4d357d2c45a/gr1_lrg.jpg)
Fat density is a novel prognostic marker in patients with esophageal cancer - Clinical Nutrition ESPEN
![Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers | Semantic Scholar Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1131a575aa4f825cd332c669e0064893b7aeca6f/2-Table1-1.png)
Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers | Semantic Scholar
![Cancers | Free Full-Text | The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers Cancers | Free Full-Text | The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers](https://www.mdpi.com/cancers/cancers-13-00720/article_deploy/html/images/cancers-13-00720-g001.png)
Cancers | Free Full-Text | The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
![Figures index : Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing Figures index : Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing](http://pubs.sciepub.com/jcrt/4/5/2/image/tab1.png)
Figures index : Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing
![Cells | Free Full-Text | Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer Cells | Free Full-Text | Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer](https://www.mdpi.com/cells/cells-09-01481/article_deploy/html/images/cells-09-01481-g001.png)
Cells | Free Full-Text | Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer
![Frontiers | Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma Frontiers | Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma](https://www.frontiersin.org/files/Articles/789312/fonc-11-789312-HTML/image_m/fonc-11-789312-g001.jpg)
Frontiers | Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
![Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers](https://www.spandidos-publications.com/article_images/mco/15/5/mco-15-05-02399-g04.jpg)
Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers
![CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report | Surgical Case Reports | Full Text CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report | Surgical Case Reports | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40792-021-01252-1/MediaObjects/40792_2021_1252_Fig1_HTML.jpg)
CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report | Surgical Case Reports | Full Text
![Frontiers | Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment Frontiers | Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment](https://www.frontiersin.org/files/MyHome%20Article%20Library/664816/664816_Thumb_400.jpg)
Frontiers | Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment
![Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging | SpringerLink Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40291-020-00448-9/MediaObjects/40291_2020_448_Fig2_HTML.png)
Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging | SpringerLink
![Cancers | Free Full-Text | Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma Cancers | Free Full-Text | Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma](https://www.mdpi.com/cancers/cancers-11-00518/article_deploy/html/images/cancers-11-00518-g001.png)